- The FDA has expanded the list of VAT-exempt medicines to include treatments for cancer, diabetes, hypertension, kidney disease, tuberculosis, and mental health conditions.
- This update aligns with President Marcos’s directive to reduce medicine costs and improve access to essential treatments.
- Additional products now qualify for VAT exemption under the CREATE Act, particularly Section 12.
- Newly listed VAT-exempt cancer medicines include Bortezomib, Docetaxel, Lenvatinib, Lenalidomide, and Paclitaxel.
- For diabetes, Saxagliptin and Dapagliflozin combination tablets have been added.
- New hypertension drugs include a combination of Losartan, Rosuvastatin, and Amlodipine in various dosages.
- The list for kidney conditions includes a peritoneal dialysis solution with specific ingredients.
- A tuberculosis treatment combining Rifampicin, Isoniazid, and Pyrazinamide is also included.
Source: palawan-news.com
Note that this post was (partially) written with the help of AI. It is always useful to review the original source material, and where needed to obtain (local) advice from a specialist.
